Loading stock data…
WST
$300.68+3.09 (+1.04%)
Market ClosedLast close May 1
West Pharmaceutical Services, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
West Pharmaceutical Services, Inc. in the Healthcare sector is trading at $300.68. The stock is currently near its 52-week high of $322.34, remaining 16.2% above its 200-day moving average. Technical signals show overbought RSI of 74 and bullish MACD crossover, explaining why WST maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 74) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$300.68
Potential Downside
47.9%
Whystock Fair Value$156.77
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus13 analysts
Buy
Mean target$349.85+16.4%
Range$310.00 – $400.00
Fundamentals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Pro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$19.78B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
40.41
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.15
Div Yield
Strong income play. Yield provides a meaningful total return floor.
32.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.36%
Volume
Today's trading volume
526,658
Recent News
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Strong 1 Year Rally?
If you are wondering whether West Pharmaceutical Services at around US$300.68 is offering good value right now, the key is to separate price excitement from underlying worth. The share price has seen mixed returns, with a 1.8% decline over the last 7 days but gains of 18.0% over 30 days, 8.8% year to date, and 42.8% over 1 year, alongside 3 year and 5 year returns of 17.7% and 8.7% declines respectively. Recent coverage has focused on West Pharmaceutical Services as investors reassess...
West Pharmaceutical (WST) Upgraded to Strong Buy: Here's What You Should Know
West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are You Looking for a Top Momentum Pick? Why West Pharmaceutical Services (WST) is a Great Choice
Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Momentum Stocks to Buy for April 29th
FIX, DVN and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 29th, 2026.
From Slide to Surge: How West Pharmaceutical Services Reclaimed Its Mojo in 2026
West Pharmaceutical Services (NYSE: WST) has ripped 24.2% in the past month and 8.7% in the past week, and the move has the fingerprints of a sustained re-rating. After a multi-year drawdown that left the stock with a five-year return of −5.7%, the injectable-containment specialist has flipped the script with a Q1 2026 print so ... From Slide to Surge: How West Pharmaceutical Services Reclaimed Its Mojo in 2026